Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerated, Hypofractionated Post-Mastectomy Radiation Therapy in Women With Breast Cancer: A Phase II Trial

NCT01417286 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT01417286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01417286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerated, Hypofractionated Post-Mastectomy Radiation Therapy in Women With Breast Cancer: A Phase II Trial
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Phase 2
Overall status
Completed
Start date
December 21, 2010
Completion date
February 20, 2020
Enrollment
69 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory breast cancer, invasive ductal breast carcinoma, invasive lobular breast carcinoma, mucinous ductal breast carcinoma, papillary ductal breast carcinoma, stage ii breast cancer, stage iiia breast cancer, stage iiib breast cancer, stage iiic breast cancer, tubular ductal breast carcinoma